Back to Search
Start Over
Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6.
- Source :
-
Oncotarget [Oncotarget] 2015 Aug 21; Vol. 6 (24), pp. 20043-57. - Publication Year :
- 2015
-
Abstract
- Follicular T helper (Tfh) cells are recognized by the expression of CXCR5 and the transcriptional regulator Bcl-6. Tfh cells control B cell maturation and antibody production, and if deregulated, may lead to autoimmunity. Here, we study the role of the proto-oncogene survivin in the formation of Tfh cells. We show that blood Tfh cells of patients with the autoimmune condition rheumatoid arthritis, have intracellular expression of survivin. Survivin was co-localized with Bcl-6 in the nuclei of CXCR5+CD4 lymphocytes and was immunoprecipitated with the Bcl-6 responsive element of the target genes. Inhibition of survivin in arthritic mice led to the reduction of CXCR5+ Tfh cells and to low production of autoantibodies. Exposure to survivin activated STAT3 and induced enrichment of PD-1+Bcl-6+ subset within Tfh cells. Collectively, our study demonstrates that survivin belongs to the Tfh cell phenotype and ensures their optimal function by regulating transcriptional activity of Bcl-6.
- Subjects :
- Animals
Autoimmunity immunology
DNA-Binding Proteins chemistry
DNA-Binding Proteins genetics
DNA-Binding Proteins metabolism
Genes, p53
Humans
Inhibitor of Apoptosis Proteins chemistry
Inhibitor of Apoptosis Proteins metabolism
Male
Mice
Mice, Inbred DBA
Models, Molecular
Positive Regulatory Domain I-Binding Factor 1
Protein Structure, Secondary
Proto-Oncogene Mas
Proto-Oncogene Proteins c-bcl-6
Repressor Proteins genetics
Repressor Proteins immunology
Survivin
CD4-Positive T-Lymphocytes immunology
DNA-Binding Proteins immunology
Inhibitor of Apoptosis Proteins immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1949-2553
- Volume :
- 6
- Issue :
- 24
- Database :
- MEDLINE
- Journal :
- Oncotarget
- Publication Type :
- Academic Journal
- Accession number :
- 26343374
- Full Text :
- https://doi.org/10.18632/oncotarget.4994